Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 1.674
-0.016 (-0.95%)
Jan 30, 2026, 5:29 PM CET
Advicenne Market Cap
Advicenne has a market cap or net worth of €23.72 million as of January 30, 2026. Its market cap has decreased by -6.94% in one year.
Market Cap
23.72M
Enterprise Value
41.87M
Revenue
5.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.67
Market Cap Chart
Since December 6, 2017, Advicenne's market cap has decreased from 112.04M to 23.72M, a decrease of -78.83%. That is a compound annual growth rate of -17.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 23.72M | -3.24% |
| Dec 31, 2025 | 24.51M | 1.30% |
| Dec 31, 2024 | 24.20M | -25.97% |
| Dec 29, 2023 | 32.68M | -28.00% |
| Dec 30, 2022 | 45.40M | -51.76% |
| Dec 31, 2021 | 94.11M | 11.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valerio Therapeutics Société anonyme | 69.17M |
| Fermentalg | 41.13M |
| THX Pharma Société Anonyme | 34.49M |
| Nicox | 31.73M |
| genOway Société anonyme | 22.77M |
| Aelis Farma | 21.00M |
| Poxel | 17.95M |
| GenSight Biologics | 17.40M |